Narrow search
Showing 1 - 10 of 5,724
Cover Image
Choosing among Competing Blockbusters: Does the Identity of the Third-Party Payer Matter for Prescribing Doctors?
Dalen, Dag Morten; Sorisio, Enrico; Strøm, Steinar - CESifo - 2010
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 % of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper examines to what extent the identity of the...
Persistent link: https://www.econbiz.de/10008727300
Cover Image
Longitudinal Analysis of Generic Substitution
Dalen, Dag Morten; Locatelli, Marilena; Strøm, Steinar - CESifo - 2010
Using an extensive longitudinal dataset extracted from the Norwegian Prescription Database (NorPD) containing all prescriptions written in the period January 2004 to June 2007, we selected two particular drugs (chemical substances) used against cholesterol. The two brand-name products on the...
Persistent link: https://www.econbiz.de/10008671717
Cover Image
A probability approach to pharmaceutical demand and price setting: Does the identity of the third-party payer matters for prescribing doctors?
Dalen, Dag Morten; Locatelli, Marilena; Sorisio, Enrico; … - 2011
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 per cent of total pharmaceutical sale in Norway. Novelty of the paper is to examine, with the use of a unique natural policy experiment in Norway, to what...
Persistent link: https://www.econbiz.de/10010278848
Cover Image
A probability approach to pharmaceutical demand and price setting : does the identity of the third-party payer matters for prescribing doctors?
Dalen, Dag Morten; Locatelli Biey, Marilena; Sorisio, Enrico - 2011
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 per cent of total pharmaceutical sale in Norway. Novelty of the paper is to examine, with the use of a unique natural policy experiment in Norway, to what...
Persistent link: https://www.econbiz.de/10009377790
Cover Image
A Probability Approach to Pharmaceutical Demand and Price Setting : Does the Identity of the Third-Party Payer Matters for Prescribing Doctors?
Dalen, Dag Morten - 2011
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 per cent of total pharmaceutical sale in Norway. Novelty of the paper is to examine, with the use of a unique natural policy experiment in Norway, to what...
Persistent link: https://www.econbiz.de/10013118139
Cover Image
Does the Identity of the Third-Party Payer Matter for Prescribing Doctors?
Dalen, Dag Morten; Locatelli, Marilena; Sorisio, Enrico; … - In: Applied Economics and Finance 1 (2014) 1, pp. 39-54
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 per cent of total pharmaceutical sale in Norway. Novelty of the paper is to examine, with the use of a unique natural policy experiment in Norway, to what...
Persistent link: https://www.econbiz.de/10010757740
Cover Image
Choosing among competing blockbusters: Does the identity of the third-party payer matter for prescribing doctors?
Dalen, Dag Morten; Sorisio, Enrico; Strøm, Steinar - 2010
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 % of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper examines to what extent the identity of the...
Persistent link: https://www.econbiz.de/10010274801
Cover Image
Choosing Among Competing Blockbusters : Does the Identity of the Third-Party Payer Matter for Prescribing Doctors?
Dalen, Dag Morten - 2010
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8% of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper examines to what extent the identity of the...
Persistent link: https://www.econbiz.de/10013136585
Cover Image
Choosing among competing blockbusters : does the identity of the third-party payer matter for prescribing doctors?
Dalen, Dag Morten; Sorisio, Enrico; Strøm, Steinar - 2010
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 % of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper examines to what extent the identity of the...
Persistent link: https://www.econbiz.de/10008699739
Cover Image
Choosing among Competing Blockbusters: Does the Identity of the Third-party Payer Matter for Prescribing Doctors?
Dalen, Dag Morten; Sorisio, Enrico; Strøm, Steinar - Økonomisk institutt, Universitetet i Oslo - 2009
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 % of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper examines to what extent the identity of the...
Persistent link: https://www.econbiz.de/10004967612